About LOF Media
LOF Media is a company based in Stevenage (United Kingdom) founded in 2017 was acquired by Bayer in August 2020. It operates as a Professional Services. LOF Media has raised $32.21 million across 1 funding round from investors including Bayer, Orbimed and Advent Life Sciences. LOF Media offers products and services including Audiovisual Content Production, Documentary Projects, and Television Entertainment. LOF Media operates in a competitive market with competitors including Tarsa Therapeutics, Sojournix, Ascend Therapeutics, Vertical Pharmaceuticals and MenoGeniX, among others.
- Headquarter Stevenage, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Love Our Films Media, S.L.
-
Annual Revenue
Not available
-
Net Profit
-$5.67 M (USD)88as on Dec 31, 2021
-
EBITDA
-$5.67 M (USD)89as on Dec 31, 2021
-
Total Equity Funding
$32.21 M (USD)
in 1 rounds
-
Latest Funding Round
$32.21 M (USD), Series C
Aug 28, 2018
-
Investors
Bayer
& 5 more
-
Employee Count
Not available
-
Acquired by
Bayer
(Aug 11, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LOF Media
LOF Media offers a comprehensive portfolio of products and services, including Audiovisual Content Production, Documentary Projects, and Television Entertainment.
Audiovisual content is created for cinema and television.
Documentary projects are produced for various media platforms.
Entertainment content is developed for television broadcast purposes.
Funding Insights of LOF Media
LOF Media has successfully raised a total of $32.21M through 1 strategic funding round. The most recent funding activity was a Series C round of $32.21 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LOF Media
LOF Media has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Bayer, Orbimed and Advent Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and mid-stage life science focused VC firm investing in the US and Europe
|
Locked | Locked | Locked | |
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
Risk capital is provided to life sciences entrepreneurs.
|
Locked | Locked | Locked |
Investor details for LOF Media
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LOF Media
Investment portfolio details for LOF Media
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LOF Media
Detailed financials for LOF Media
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lof Media Comparisons
Peer comparison for LOF Media
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LOF Media
LOF Media operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tarsa Therapeutics, Sojournix, Ascend Therapeutics, Vertical Pharmaceuticals and MenoGeniX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oral treatments for postmenopausal osteoporosis are developed.
|
|
| Locked | Locked | Locked |
Online platform offering gaming agency with registration, login, and promotional features.
|
|
| Locked | Locked | Locked |
Specialty pharmaceuticals for women's healthcare are developed by Ascend Therapeutics.
|
|
| Locked | Locked | Locked |
Develops and distributes prescription drugs for women's health, pain, and mental health treatments.
|
|
| Locked | Locked | Locked |
Drugs for menopause and cancer-related vasomotor symptoms are developed.
|
|
| Locked | Locked | Locked |
Viramal is focused on developing transformative medicines for women.
|
Detailed competitors of LOF Media
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lof Media
Complete news archive for LOF Media
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LOF Media
LOF Media was founded in 2017 and raised its 1st funding round 1 year after it was founded.
LOF Media is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.
LOF Media is a funded company, having raised a total of $32.21M across 1 funding round to date.
Audiovisual content is created and produced by LOF Media, based in Valencia, Spain, since 2018. Focus is placed on fiction formats for cinema and television, alongside documentary projects and entertainment for television. Events in the audiovisual sector are also managed. A deep understanding of the audiovisual industry and its processes is maintained, with an emphasis on quality and respect for the audience. Creativity is prioritized at every stage, from conception to distribution, aiming for excellence in both process and outcome.
LOF Media's top competitors include Ovoca Bio, Viramal and Tarsa Therapeutics.
LOF Media offers Audiovisual Content Production, Documentary Projects, and Television Entertainment.
LOF Media has 6 investors. Key investors include Bayer, Orbimed, Advent Life Sciences, Forbion, and Fountain Healthcare Partners.